Literature DB >> 2950165

Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies.

W Stohl, D N Posnett, N Chiorazzi.   

Abstract

Three monoclonal antibodies (mAb) recognizing the CD3 (T3) surface complex each induced B cell differentiation (as measured by PFC generation) in cultures containing T + non-T cells. Irradiation of the T cells before culture usually augmented the PFC response. An IgG2a mAb (454) induced PFC in all donors tested, whereas two IgG1 mAb (147 and 446) induced PFC in only 80% of the donors tested. This heterogeneity in PFC response to IgG1 anti-CD3 mAb strictly paralleled the heterogeneity in proliferative response to IgG1 anti-CD3 mAb and was governed by cells within the non-T population. In IgG1 anti-CD3 high responders (HR), all anti-CD3 mAb tested induced Tac expression. In IgG1 anti-CD3 low responders (LR), mAb 454 induced Tac expression, but mAb 147 did not. However, when the cultures were supplemented with exogenous interleukin 2, Tac expression and PFC generation in response to mAb 147 was similar to the response to mAb 454 in both HR and LR. The addition of anti-Tac to the cultures partially inhibited anti-CD3-induced PFC generation. These studies indicate that anti-CD3 mAb can lead to B cell differentiation under appropriate experimental conditions and may be valuable in studying polyclonal T cell-dependent B cell differentiation in normal and disease states.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2950165

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity.

Authors:  William Stohl; Noam Jacob; Shunhua Guo; Laurence Morel
Journal:  Arthritis Rheum       Date:  2010-08

2.  Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.

Authors:  J Zamorano; D Rivas; A Gayo; L Mozo; C Gutiérrez
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

3.  Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA.

Authors:  N Oyaizu; N Chirmule; V S Kalyanaraman; W W Hall; R Pahwa; M Shuster; S Pahwa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF.

Authors:  Chaim O Jacob; Luminita Pricop; Chaim Putterman; Michael N Koss; Yi Liu; Maria Kollaros; Sarah A Bixler; Christine M Ambrose; Martin L Scott; William Stohl
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

5.  Analysis of autoantibody production in SCID-systemic lupus erythematosus (SLE) chimeras.

Authors:  D Ashany; J Hines; A Gharavi; J Mouradian; K B Elkon
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

6.  Clonal analysis of functionally distinct human CD4+ T cell subsets.

Authors:  F T Rotteveel; I Kokkelink; R A van Lier; B Kuenen; A Meager; F Miedema; C J Lucas
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

7.  Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.

Authors:  Z M Sthoeger; M Wakai; D B Tse; V P Vinciguerra; S L Allen; D R Budman; S M Lichtman; P Schulman; L R Weiselberg; N Chiorazzi
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

8.  Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells.

Authors:  S M Friedman; M K Crow; J R Tumang; M Tumang; Y Q Xu; A S Hodtsev; B C Cole; D N Posnett
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

9.  Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.

Authors:  E A Ranheim; T J Kipps
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.